Forte Biosciences, Inc. (FBRX) News

Forte Biosciences, Inc. (FBRX): $1.32

0.02 (+1.54%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add FBRX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 416

in industry

Filter FBRX News Items

FBRX News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest FBRX News From Around the Web

Below are the latest news stories about Forte Biosciences Inc that investors may wish to consider to help them evaluate FBRX as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Good morning!

William White on InvestorPlace | February 8, 2022

Following Its 52-Week Low, Forte Biosciences Inc. (NASDAQ: FBRX)’S Share Price Rose 8.41% And Its YTD Numbers Fell -94.12%

During the last session, Forte Biosciences Inc. (NASDAQ:FBRX)’s traded shares were 3.02 million, with the beta value of the company hitting 0.67. At the end of the trading day, the stock’s price was $2.14, reflecting an intraday gain of 5.94% or $0.12. The 52-week high for the FBRX share is $43.57, that puts it down … Following Its 52-Week Low, Forte Biosciences Inc. (NASDAQ: FBRX)’S Share Price Rose 8.41% And Its YTD Numbers Fell -94.12% Read More »

Marketing Sentinel | December 17, 2021

Here's Why We're Watching Forte Biosciences' (NASDAQ:FBRX) Cash Burn Situation

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Yahoo | December 15, 2021

Forte Biosciences, Inc. (NASDAQ:FBRX) Expected to Post Earnings of -$0.38 Per Share

Wall Street analysts predict that Forte Biosciences, Inc. (NASDAQ:FBRX) will post earnings of ($0.38) per share for the current quarter, Zacks reports. Zero analysts have provided estimates for Forte Biosciences earnings. The business is scheduled to announce its next quarterly earnings results on Wednesday, March 23rd. According to Zacks, analysts expect that Forte Biosciences will []

Transcript Daily | December 8, 2021

Forte Biosciences Inc. (FBRX) At $2.24: Is It Worth Your Interest?

Forte Biosciences Inc. (NASDAQ:FBRX) concluded the trading at $2.24 on Friday, December 03 with a fall of -7.44% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $2.42 with its price kept floating in the range of $2.22 and $2.42 on the Forte Biosciences Inc. (FBRX) At $2.24: Is It Worth Your Interest? Read More »

Stocks Register | December 4, 2021

Forte Biosciences, Inc. (NASDAQ:FBRX) Short Interest Down 35.8% in November

Forte Biosciences, Inc. (NASDAQ:FBRX) was the target of a significant decline in short interest in the month of November. As of November 15th, there was short interest totalling 719,200 shares, a decline of 35.8% from the October 31st total of 1,120,000 shares. Based on an average trading volume of 2,350,000 shares, the days-to-cover ratio is []

Transcript Daily | December 3, 2021

Forte Biosciences, Inc. (NASDAQ:FBRX) Receives Average Rating of Hold from Analysts

Forte Biosciences, Inc. (NASDAQ:FBRX) has earned an average recommendation of Hold from the ten brokerages that are covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and one has given a buy rating to the company. The average 1-year price objective []

Dakota Financial News | November 26, 2021

Should You Expect A Quick Recovery From Forte Biosciences Inc. (NASDAQ: FBRX) After -1412.85% Decline From High?

Forte Biosciences Inc. (NASDAQ:FBRX)s traded shares stood at 0.32 million during the last session, with the companys beta value hitting 0.67. At the close of trading, the stocks price was $2.88, to imply a decrease of 0.00% or $0.0 in intraday trading. The FBRX shares 52-week high remains $43.57, putting it -1412.85% down since that Should You Expect A Quick Recovery From Forte Biosciences Inc. (NASDAQ: FBRX) After -1412.85% Decline From High? Read More »

Marketing Sentinel | November 20, 2021

Forte Biosciences (NASDAQ:FBRX) Downgraded by Zacks Investment Research to Hold

Zacks Investment Research lowered shares of Forte Biosciences (NASDAQ:FBRX) from a buy rating to a hold rating in a report issued on Friday, Zacks.com reports. According to Zacks, Forte Biosciences Inc. is a clinical stage, dermatology company. It engages in developing biotherapeutic, FB-401, for the treatment of inflammatory skin diseases which is in clinical stage. []

Dakota Financial News | November 20, 2021

Forte Biosciences, Inc. (NASDAQ:FBRX) Expected to Announce Earnings of -$0.25 Per Share

Wall Street brokerages expect Forte Biosciences, Inc. (NASDAQ:FBRX) to announce ($0.25) earnings per share for the current quarter, according to Zacks. Zero analysts have provided estimates for Forte Biosciences earnings, with the lowest EPS estimate coming in at ($0.38) and the highest estimate coming in at ($0.11). The firm is scheduled to announce its next []

Dakota Financial News | November 18, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6052 seconds.